PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.18%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
0.26%
Some D&A expansion while AVGO is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1028.57%
Negative yoy deferred tax while AVGO stands at 17.96%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-58.21%
Negative yoy working capital usage while AVGO is 18.76%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
104.24%
Inventory growth well above AVGO's 26.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-317.65%
Negative yoy usage while AVGO is 68.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
440.00%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.92%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-43.83%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-11.34%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.22%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
-76.52%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-63.83%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
1.64%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.